Apixaban Twice Daily vs Rivaroxaban Once Daily for the Treatment of Venous Thromboembolism: A randomised controlled trial

  • Chen, Vivien (Primary Chief Investigator (PCI))
  • Castellucci, Lana (Chief Investigator (CI))
  • Brighton, Timothy (Chief Investigator (CI))
  • Tran, Huyen (Chief Investigator (CI))
  • Rodger, Marc (Chief Investigator (CI))
  • Le Gal, Grégoire (Chief Investigator (CI))
  • Kahn, Susan (Chief Investigator (CI))
  • Simes, R John (Chief Investigator (CI))
  • Reddel, Caroline (Chief Investigator (CI))
  • Morton, Rachael L. (Chief Investigator (CI))

Project: Research

Project Details

Short titleComparison of Bleeding Risk between Rivaroxaban and Apixaban for the treatment of acute venous thromboembolism
AcronymCOBRRA
StatusActive
Effective start/end date1/02/2031/01/24